How to evaluate a stock before you buy it

Topic: Investment · Type: Evergreen · Reading time: ~8 min

Most people buy their first stock the same way they buy a lottery ticket. Something caught their eye — a tip from a colleague, a headline, a ticker that was up 40% in a week — and they clicked buy before they'd spent ten minutes thinking about what they were actually purchasing.

That's not entirely their fault. The standard guides on how to evaluate a stock before you buy it tend to dump a wall of ratios on you and leave you to figure out how they fit together. This post does something different: it gives you a working sequence, not just a list of metrics.

Why "do your research" is not actually advice

Everyone tells you to research stocks before you buy them. Very few people explain what that research looks like in practice.

Here is the honest context: over the 20-year period from 2005 to 2024, 94.1% of US actively managed domestic funds underperformed the S&P 1500 Composite Index, according to S&P Global's SPIVA Scorecard. Over the 15-year period ending December 2024, not a single one of the 22 US equity fund categories had a majority of active managers beating their benchmarks. These are professionals with Bloomberg terminals, research teams, and decades of experience — and they still lose to passive index funds over meaningful time horizons.

This doesn't mean individual stock research is pointless. It means the bar is higher than most people assume, and the research process matters more than the specific stock you land on. If you're going to pick stocks at all, you need a process worth taking seriously. If you'd prefer not to, a globally diversified index fund strategy is a legitimate alternative that most professionals quietly recommend.

Step 1 — Understand what the company actually does

This sounds obvious. It isn't.

Before touching a single ratio, you should be able to answer three questions about the company in plain language: What does it sell? Who pays for it? How does it make money after costs?

If you can't explain the business in two sentences without using the word "solutions," that's a warning sign — not necessarily about the company, but about your own understanding of it. Warren Buffett's famous circle of competence isn't a metaphor; it's a practical filter. Investing in a business you don't understand means you have no basis for knowing when your original thesis breaks down.

Read the most recent annual report. Not the whole thing — start with the letter to shareholders and the "Management Discussion and Analysis" section. These tell you what the company's own leadership thinks is going well, what's under pressure, and what risks they're watching. Companies are required by law to disclose risks in these documents. The ones that disclose them candidly are often better managed than the ones that don't.

Step 2 — Check valuation with the right tool for the sector

The price-to-earnings (P/E) ratio is the most quoted valuation metric in investing. It compares a company's stock price to its annual earnings per share. If a stock trades at £50 and earns £2.50 per share, its P/E is 20 — meaning you're paying £20 for every £1 of profit it currently generates.

The long-run average P/E for the S&P 500 is around 18. As of early 2025, the trailing P/E sat around 24, with the forward P/E (based on projected earnings) closer to 21 — reflecting market expectations of continued earnings growth. Neither number tells you much on its own.

The critical point most beginner guides miss: P/E ratios are only meaningful when compared within sectors, not across them. The consumer staples sector has historically traded at a 10-year average forward P/E of around 18.9; the financial sector averages closer to 12.9. Comparing a utility company's P/E to a software company's P/E is like comparing a property's rent yield to a startup's revenue multiple — they're measuring different things.

For companies with little or no earnings — common in high-growth tech — the P/E is useless. Software investors often use the price-to-sales ratio (P/S) instead, or the "Rule of 40," which holds that a company's revenue growth rate plus profit margin should combined exceed 40% to be considered healthy. Banks and insurance companies are better assessed using price-to-book (P/B) and return on equity (ROE).

Worth knowing: The forward P/E can be artificially low early in the year, because analyst estimates tend to start optimistic and get revised downward as the year progresses. A stock that looks cheap in January may not look as cheap by Q3. Check the history of earnings revisions, not just the current estimate.

Step 3 — Look at free cash flow, not just earnings

Earnings are an accounting figure. Free cash flow (FCF) is cash.

A company reports earnings by following accounting rules, which involve judgment calls on depreciation, amortisation, write-downs, and timing. Free cash flow is what's left after a company has paid its operating expenses and made the capital investments needed to maintain or grow the business. It's the number that tells you whether the business is genuinely generating money or just reporting it on paper.

A company with rising earnings but flat or declining free cash flow deserves scrutiny. The reverse — falling earnings but strong cash generation — might signal an undervalued business.

Calculating free cash flow is straightforward: take operating cash flow from the cash flow statement and subtract capital expenditure (also on that statement). Free cash flow yield — FCF divided by market capitalisation — lets you compare this against the P/E. A business with a P/E of 25 but an FCF yield of 6% is often in better shape than the P/E alone suggests.

This is also where the value trap problem shows up. A stock can look cheap on P/E while simultaneously generating deteriorating cash flows, losing market share, or carrying unsustainable debt. Always ask: is this cheap because it's overlooked, or because the market is right to be sceptical?

Step 4 — Assess the competitive position honestly

Ratios tell you what a business has done. The competitive position tells you whether it can keep doing it.

Look for evidence of durable advantages: pricing power (can the company raise prices without losing customers?), switching costs (how hard is it for customers to leave?), network effects (does the product get more valuable as more people use it?), or cost advantages that competitors can't easily replicate.

Be sceptical of moats you can't verify. Every company's investor relations page describes a strong competitive position. The test is whether the financials corroborate it. Consistent gross margins above industry peers over five or more years is one of the clearest signals that a competitive advantage is real, not just claimed.

Also look at who's running the company and what they own. A management team with significant skin in the game — meaning they hold a meaningful percentage of shares, not a token amount — tends to make better long-term decisions than one whose compensation is entirely salary and short-term bonus. This is imperfect, but it's a useful filter.

Step 5 — Compare price to a rough estimate of fair value

This is the part most guides either skip entirely or overcomplicate with discounted cash flow models that require 15 inputs and produce false precision.

A simpler approach for most situations: compare the stock's current P/E (or P/FCF) to its historical average and to the average of its direct peers. If a company has historically traded at a forward P/E of 20 and is currently trading at 30 with no meaningful change in growth expectations, it's either more expensive than usual for a reason, or it's expensive and the market hasn't noticed yet. Both are worth investigating.

Building a diversified portfolio from scratch is the next logical step after you understand individual stock evaluation — because single stock positions carry concentration risk that most investors underestimate.

Consider the margin of safety concept, from Benjamin Graham's value investing tradition: buy at a meaningful discount to what you believe something is worth, to give yourself room to be wrong. The right margin depends on the business quality and certainty of your analysis. A stable, predictable business warrants a smaller buffer; a smaller, riskier company requires a larger one.

What this means for you

Evaluating a stock before you buy it is not about running 20 ratios and producing a spreadsheet. It's about building enough conviction in the business to hold through a 30% drawdown without panicking — because that's eventually what stock ownership looks like.

The sequence that works: understand the business first, check the valuation in sector context, verify the earnings story with cash flow, assess the competitive position honestly, and then decide whether the price reflects what you know. If you can't get comfortable with all five, that's not a failure of analysis — it's the analysis telling you something useful.

One concrete action: before your next purchase, write down in two sentences why you believe this company will be worth more in five years than it is today, and what specific event or development would change your mind. If you can't complete both parts, you're not ready to buy it yet.